Codexis, Inc. (CDXS) Stock

Healthcare · Biotechnology · Member of Other US Stocks

Codexis, Inc. (CDXS) closed at USD 1.29 on 2026-10-14, a change of -50.2 % over the past year, with a market capitalization of USD 148.93M.

Codexis, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Codexis, Inc. key figures

Previous close

USD 1.29 (2026-10-14)

1-year change

-50.2 %

Market cap

USD 148.93M

Enterprise value

USD 166.6M

P/E ratio (trailing)

-4.00

P/E ratio (forward)

-4.25

EPS (trailing)

-0.34

EPS (forward)

-0.32

PEG ratio

13.53

Price to book

3.77

Revenue growth

-2.7 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

5.54

Employees

146

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Codexis, Inc.

Codexis, Inc. provides technology solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, enhance, and commercialize novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China. The company develops its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. It has a license agreement with Aldevron LLC and Pfizer Inc. The company was incorporated in 2002 and is headquartered in Redwood City, California.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Codexis, Inc. and compare it with other stocks.